Balanced news tone
News Sentiment
4565 sentiment intelligence
Nxera Pharma Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
73/100 classification confidence.
directly relevant articles
high-authority source matches
-5.3% over one week, -6.5% over four weeks, trend active, and below fair value.
Nxera Pharma to announce 2Q2026 results on August 7
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Nxera Pharma to announce 2Q2026 results on August 7
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 10:07
- Source
- scanx.trade
Nxera Pharma Webinar for Financial Results Presentation - 2Q2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 09:31
- Source
- The Manila Times
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Market source
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 Mar 2026 07:00
- Source
- Market source
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Mar 2026 08:00
- Source
- Market source